ENTRY       K05866                      KO
NAME        CDC25B
DEFINITION  M-phase inducer phosphatase 2 [EC:3.1.3.48]
PATHWAY     ko04010  MAPK signaling pathway
            ko04110  Cell cycle
            ko04914  Progesterone-mediated oocyte maturation
            ko05206  MicroRNAs in cancer
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Environmental Information Processing
              Signal transduction
               04010 MAPK signaling pathway
                K05866  CDC25B; M-phase inducer phosphatase 2
             Cellular Processes
              Cell growth and death
               04110 Cell cycle
                K05866  CDC25B; M-phase inducer phosphatase 2
             Organismal Systems
              Endocrine system
               04914 Progesterone-mediated oocyte maturation
                K05866  CDC25B; M-phase inducer phosphatase 2
             Human Diseases
              Cancers
               05206 MicroRNAs in cancer
                K05866  CDC25B; M-phase inducer phosphatase 2
            Enzymes [BR:ko01000]
             3. Hydrolases
              3.1  Acting on ester bonds
               3.1.3  Phosphoric-monoester hydrolases
                3.1.3.48  protein-tyrosine-phosphatase
                 K05866  CDC25B; M-phase inducer phosphatase 2
            Protein phosphatases and associated proteins [BR:ko01009]
             Protein Tyrosine phosphatases (PTPs)
              Class III PTPs
               CDC25s
                K05866  CDC25B; M-phase inducer phosphatase 2
DBLINKS     GO: 0004725
GENES       HSA: 994(CDC25B)
            PTR: 458064(CDC25B)
            PPS: 100978502(CDC25B)
            GGO: 101127265(CDC25B)
            PON: 100434256(CDC25B)
            MCF: 102135274(CDC25B)
            MMU: 12531(Cdc25b)
            RNO: 171103(Cdc25b)
            CGE: 100765509(Cdc25b)
            HGL: 101701077(Cdc25b)
            TUP: 102474077(CDC25B)
            CFA: 485790(CDC25B)
            AML: 100483177(CDC25B)
            FCA: 101092757(CDC25B)
            PTG: 102962278(CDC25B)
            BTA: 505847(CDC25B)
            BOM: 102276738(CDC25B)
            PHD: 102315199(CDC25B)
            CHX: 102179213(CDC25B)
            SSC: 100329127(CDC25B)
            CFR: 102521503(CDC25B)
            BACU: 103012203(CDC25B)
            LVE: 103081717(CDC25B)
            ECB: 100052425(CDC25B)
            MYB: 102244544(CDC25B)
            MYD: 102766417(CDC25B)
            PALE: 102893112(CDC25B)
            SHR: 100927310(CDC25B)
            OAA: 100075940(CDC25B)
            MGP: 100548933
            TGU: 100220295
            PHI: 102106150
            FPG: 101922961(CDC25B)
            FCH: 102053620(CDC25B)
            CLV: 102087487(CDC25B)
            ASN: 102369674(CDC25B)
            AMJ: 102576728(CDC25B)
            CMY: 102929649(CDC25B)
            ACS: 100568149
            PBI: 103054614(CDC25B)
            XLA: 100158454(cdc25b-a) 100158455(cdc25b-b)
            XTR: 100036608(cdc25b)
            DRE: 57925(cdc25)
            TRU: 101069500
            MZE: 101482927
            OLA: 101168663
            XMA: 102234056
            LCM: 102366036(CDC25B)
            CMK: 103181515
            SPU: 576121
            ACAN: ACA1_182960
REFERENCE   PMID:16682204
  AUTHORS   Karlsson-Rosenthal C, Millar JB
  TITLE     Cdc25: mechanisms of checkpoint inhibition and recovery.
  JOURNAL   Trends Cell Biol 16:285-92 (2006)
///
